Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration (Q37318998)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2013

Language	Label	Description	Also known as
English	Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration	scientific article published on September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Sachin Jain

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kamal Kishore

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Yog Raj Sharma

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

1 September 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Indian Journal of Ophthalmology

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

61

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

490-496

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Submacular haemorrhages associated with neovascular age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Pneumatic displacement and intravitreal bevacizumab: a new approach for management of submacular hemorrhage in choroidal neovascular membrane

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

9 September 2017

Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Causes and prevalence of visual impairment among adults in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Intravitreal gas for submacular haemorrhage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

2 September 2018

Factors prognostic of visual outcome in patients with subretinal hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831764

3 December 2018

Intravitreal tissue plasminogen activator in submacular haemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure to detect an effect of pneumatic displacement in the management of submacular haemorrhage secondary to age-related macular degeneration: a retrospective case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental subretinal hemorrhage in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subretinal hemorrhage management by pars plana vitrectomy and internal drainage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrin directs early retinal damage after experimental subretinal hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transmission electron microscopic study of a subretinal choroidal neovascular membrane due to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variations in the clinical course of submacular hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/24104707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/0301-4738.119432

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37318998&oldid=2127897940"